Vanessa Stevens

Vanessa Stevens, PhD

Languages spoken: English

Academic Information

Departments Adjunct - Pediatrics , Adjunct - Population Health Sciences , Primary - Internal Medicine

Divisions: Epidemiology , Infectious Diseases

Education History

Undergraduate University of Rochester College of Arts and Sciences
 BS
Doctoral Training University of Rochester School of Medicine and Dentistry
 PhD

Selected Publications

Journal Article

  1. Nelson RE, Deka R, Khader K, Stevens VW, Schweizer ML, Rubin M (2017). Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature. American journal of infection control, 45(12), 1382-1387.
  2. Brown KA, Jones M, Daneman N, Adler FR, Stevens V, Nechodom KE, Goetz MB, Samore MH, Mayer (2016). Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care: A Multilevel Case-Control Study. Annals of internal medicine, 164(12), 787-94.
  3. Stevens VW, Stenehjem DD, Patterson OV, Kamauu AWC, Yim YM, Morlock RJ, DuVall S (2018). Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review. Archives of dermatological research, 310(6), 505-513.
  4. Brown KA, Daneman N, Jones M, Nechodom K, Stevens V, Adler FR, Goetz MB, Mayer J, Samore (2017). The Drivers of Acute and Long-term Care Clostridium difficile Infection Rates: A Retrospective Multilevel Cohort Study of 251 Facilities. Clinical infectious diseases, 65(8), 1282-1288.
  5. Stevens VW, Khader K, Echevarria K, Nelson RE, Zhang Y, Jones M, Timbrook TT, Samore MH, Rubin M (2020). Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci. Clinical infectious diseases, 71(3), 645-651.
  6. Jasper AS, Musuuza JS, Tischendorf JS, Stevens VW, Gamage SD, Osman F, Safdar (2021). Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis. Clinical infectious diseases, 72(11), 1979-1989.
  7. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens V (2021). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clinical infectious diseases, 72(4), 675-681.
  8. Christensen MA, Nevers M, Ying J, Haroldsen C, Stevens V, Jones MM, Yarbrough PM, Goetz MB, Restrepo MI, Madaras-Kelly K, Samore MH, Jones B (2021). Simulated Adoption of 2019 Community-Acquired Pneumonia Guidelines Across 114 Veterans Affairs Medical Centers: Estimated Impact on Culturing and Antibiotic Selection in Hospitalized Patients. Clinical infectious diseases, 72(Suppl 1), S59-S67.
  9. Khader K, Thomas A, Huskins WC, Stevens V, Keegan LT, Visnovsky L, Samore M (2021). Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units. Clinical infectious diseases, 72(Suppl 1), S42-S49.
  10. Nelson RE, Goto M, Samore MH, Jones M, Stevens VW, Evans ME, Schweizer ML, Perencevich EN, Rubin M (2021). Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens. Clinical infectious diseases, 72(Suppl 1), S50-S58.
  11. Khader K, Munoz-Price LS, Hanson R, Stevens V, Keegan LT, Thomas A, Pezzin LE, Nattinger A, Singh S, Samore M (2021). Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units. Clinical infectious diseases, 72(Suppl 1), S1-S7.
  12. Nelson RE, Lautenbach E, Chang N, Jones M, Willson T, David M, Linkin D, Glick H, Doshi JA, Stevens V (2021). Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center. Clinical infectious diseases, 72(Suppl 1), S27-S33.
  13. Nelson RE, Stevens VW, Khader K, Jones M, Samore MH, Evans ME, Douglas Scott R 2nd, Slayton RB, Schweizer ML, Perencevich EL, Rubin M (2016). Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections. American journal of preventive medicine, 50(5 Suppl 1), S58-S65.
  14. Khadem T, Stevens V, Holt K, Hoffmann C, Dumyati G, Brown (2017). Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa: Case-control study. Diagnostic microbiology and infectious disease, 89(2), 146-150.
  15. Brown KA, Daneman N, Stevens VW, Zhang Y, Greene TH, Samore MH, Arora (2016). Integrating Time-Varying and Ecological Exposures into Multivariate Analyses of Hospital-Acquired Infection Risk Factors: A Review and Demonstration. Infection control and hospital epidemiology, 37(4), 411-9.
  16. Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore M (2017). Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infection control and hospital epidemiology, 38(7), 848-856.
  17. Stevens VW, Shoemaker HE, Jones MM, Jones BE, Nelson RE, Khader K, Samore MH, Rubin M (2020). Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridioides difficile infection. Infection control and hospital epidemiology, 41(5), 510-516.
  18. Dieringer TD, Furukawa D, Graber CJ, Stevens VW, Jones MM, Rubin MA, Goetz M (2020). Inpatient antibiotic utilization in the Veterans' Health Administration during the coronavirus disease 2019 (COVID-19) pandemic. Infection control and hospital epidemiology, 42(6), 1-3.
  19. Cheng Y, Sauer B, Zhang Y, Nickman NA, Jamjian C, Stevens V, LaFleur (2018). Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection. Medicine, 97(2), e9430.
  20. Cheng Y, Nickman NA, Jamjian C, Stevens V, Zhang Y, Sauer B, LaFleur (2018). Predicting poor adherence to antiretroviral therapy among treatment-naïve veterans infected with human immunodeficiency virus. Medicine, 97(2), e9495.
  21. Stevens VW, Russo EM, Young-Xu Y, Leecaster M, Zhang Y, Zhang C, Yu H, Cai B, Gonzalez EN, Gerding DN, Lawrence J, Samore M (2021). Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials. Vaccine, 39(3), 536-544.
  22. Stenehjem DD, Au T, Sainski AM, Bauer H, Brown K, Lancaster J, Stevens V, Brixner D (2018). Impact of a genetic counseling requirement prior to genetic testing. BMC health services research, 18(1), 165.
  23. Nelson RE, Jones M, Leecaster M, Samore MH, Ray W, Huttner A, Huttner B, Khader K, Stevens VW, Gerding D, Schweizer ML, Rubin M (2016). An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model. PloS one, 11(3), e0152248.
  24. Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress A (2021). Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PloS one, 16(4), e0248080.
  25. Unni SK, Schauerhamer MB, Deka R, Tyczynski JE, Fernandes AW, Stevens V, Brixner DI, Stenehjem D (2016). BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study. Journal of ovarian research, 9, 18.
  26. Khader K, Thomas A, Jones M, Toth D, Stevens V, Samore MH, CDC Modeling Infectious Diseases in Healthcare Program (MInD-Healthcare) (2019). Variation and trends in transmission dynamics of Methicillin-resistant Staphylococcus aureus in veterans affairs hospitals and nursing homes. Epidemics, 28, 100347.
  27. Derington CG, Colantonio LD, Herrick JS, Cook J, King JB, Rosenson RS, Poudel B, Monda KL, Navar AM, Mues KE, Stevens VW, Nelson RE, Vanneman ME, Muntner P, Bress A (2021). Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. Journal of the American Heart Association, 10(8), e019254.
  28. Schwab EM, Wilkes J, Korgenski K, Hersh AL, Pavia AT, Stevens V (2016). Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients. Hospital pediatrics, 6(6), 339-44.
  29. Stevens VW, Nelson RE, Schwab-Daugherty EM, Khader K, Jones MM, Brown KA, Greene T, Croft LD, Neuhauser M, Glassman P, Goetz MB, Samore MH, Rubin M (2017). Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. JAMA internal medicine, 177(4), 546-553.
  30. Jones BE, Ying J, Stevens V, Haroldsen C, He T, Nevers M, Christensen MA, Nelson RE, Stoddard GJ, Sauer BC, Yarbrough PM, Jones MM, Goetz MB, Greene T, Samore M (2020). Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. JAMA internal medicine, 180(4), 552-560.
  31. Jones BE, Ying J, Nevers M, Alba PR, He T, Patterson OV, Jones MM, Stevens V, Shen J, Humpherys J, Peterson KS, Rutter ED, Gundlapalli AV, Weir CR, Dean NC, Fine MJ, Samore MC, Greene T (2021). Computerized Mortality Prediction for Community-acquired Pneumonia at 117 VA Medical Centers. Annals of the American Thoracic Society, 18(7), 1175-1184.
  32. Stevens VW, Thurm C, Schwab EM, Kronman MP, Gerber JS, Shah SS, Newland JG, Courter J, Parker S, Brogan TV, Hersh A (2016). Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infectious diseases and therapy, 5(1), 45-51.
  33. Peterson KS, Lewis J, Patterson OV, Chapman AB, Denhalter DW, Lye PA, Stevens VW, Gamage SD, Roselle GA, Wallace KS, Jones (2021). Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation. JMIR public health and surveillance, 7(3), e26719.
  34. Khader K, Thomas A, Stevens V, Visnovsky L, Nevers M, Toth D, Keegan LT, Jones M, Rubin M, Samore M (2021). Association Between Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus in Veterans Affairs Hospitals. JAMA network open, 4(3), e210971.
  35. Sutton JD, Stevens VW, Chang NN, Khader K, Timbrook TT, Spivak E (2020). Oral ß-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source. JAMA network open, 3(10), e2020166.
  36. Thorpe A, Fagerlin A, Butler J, Stevens V, Drews FA, Shoemaker H, Riddoch MS, Scherer L (2022). Communicating about COVID-19 vaccine development and safety. PloS one, 17(8), e0272426.
  37. Thorpe A, Fagerlin A, Drews FA, Butler J, Stevens V, Riddoch MS, Scherer L (2022). Communications to Promote Interest and Confidence in COVID-19 Vaccines. American journal of health promotion, 36(6), 976-986.
  38. Gawron LM, He T, Lewis L, Fudin H, Callegari LS, Turok DK, Stevens (2022). Oral Emergency Contraception Provision in the Veterans Health Administration: a Retrospective Cohort Study. Journal of general internal medicine,
  39. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JL (2022). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA dermatology, 158(11), 1321-1323.
  40. Levy AG, Thorpe A, Scherer LD, Scherer AM, Drews FA, Butler JM, Burpo N, Shoemaker H, Stevens V, Fagerlin (2022). Misrepresentation and Nonadherence Regarding COVID-19 Public Health Measures. JAMA network open, 5(10), e2235837.
  41. Rhoads JLW, Christensen L, Westerdahl S, Stevens V, Chapman WW, Conway (2024). Automatic Extraction of Skin and Soft Tissue Infection Status from Clinical Notes. Studies in health technology and informatics, 310, 579-583.
  42. Butler JM, Wang X, Riddoch M, Thorpe A, Stevens V, Scherer LD, Drews FA, Shoemaker H, Fagerlin (2023). Veterans and Nonveterans Coping With Stress During 4 Months of COVID-19. Annals of family medicine, 21(6), 508-516.
  43. Shoemaker HE, Thorpe A, Stevens V, Butler JM, Drews FA, Burpo N, Scherer LD, Fagerlin (2023). Telehealth Use During the COVID-19 Pandemic Among Veterans and Nonveterans: Web-Based Survey Study. JMIR formative research, 7, e42217.
  44. Goetz MB, Willson T, Rubin MA, Stevens VW, Graber C (2024). Antimicrobial use before and during COVID-19: data from 108 Veterans Affairs medical centers. Antimicrobial stewardship & healthcare epidemiology, 4(1), e109.
  45. Wieczorkiewicz JT, Skinner AM, Cheknis A, Petrella LA, Stevens VW, Wright LM, Gerding DN, Johnson (2024). Epidemiology of Clostridioides difficile infection at one hospital 10 years after an outbreak of the epidemic C. difficile strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures. Antimicrobial agents and chemotherapy, 68(8), e0069824.
  46. Livorsi DJ, Branch-Elliman W, Drekonja D, Echevarria KL, Fitzpatrick MA, Goetz MB, Graber CJ, Jones MM, Kelly AA, Madaras-Kelly K, Morgan DJ, Stevens VW, Suda K, Trautner BW, Ward MJ, Jump RL (2024). Research agenda for antibiotic stewardship within the Veterans' Health Administration, 2024-2028. Infection control and hospital epidemiology, 1-7.